[Distribution of capsular types and antimicrobial susceptibility of Streptococcus agalactiae causing infections in Argentina].
Streptococcus agalactiae is an endogenous bacterium that has emerged in the last 20 years as an etiological agent in both neonatal and perinatal infections, and in immunocompromised patients. The differentiation of the capsular polysaccharide, the presence of surface proteins c, X, R, and molecular methods allow classification in serotypes and genotypes. This identification is a useful tool for epidemiological purposes and virulence studies in this bacterium. The objective of this work was to study the serotypes and the antimicrobial susceptibility of isolates recovered from invasive diseases in different areas of Argentina. In the analyzed sample a fair predominance of Ia and III serotypes was recovered, followed by II and IV serotypes. All the isolates were found to be sensitive to penicillin. A 6% of resistance to erythromycin and a 4.5% to clindamycin were detected. In three of the isolates, constitutive MLS phenotype (resistance to macrolides, lincosamins and streptogramins) was founded, while in the remaining one, inducible MLS phenotype was detected. These results stress the importance of conducting a surveillance of the prevalent serotypes in our country with the goal of future prevention of this disease with an effective vaccine. The knowledge of the antimicrobial susceptibility profile will be also important to obtain therapeutic success in the treatment.
Pérez
J
J
Cátedra de Bacteriología, Depto de Microbiología, Fac. Ciencias Bioquímicas y Farmacéuticas, UNR, Suipacha 531, 2000, Rosario, Argentina.
Limansky
A
A
Toresani
I
I
Ebner
G
G
Di Bartolomeo
S
S
de Inocenti
I
I
Pretto
G
G
Salazar
N
N
Laferrara
M
M
Bottiglieri
M
M
Ballester
D
D
Morales
M
M
Rivera
L
L
Cacace
M L
ML
Castro
H
H
Roldán
L
L
Notario
R
R
Borda
N
N
Cera
G
G
Spoletti
M J
MJ
Gregorini
E
E
Sutich
E G
EG
D001118:Argentina; D024881:Drug Resistance, Bacterial; D006801:Humans; D008826:Microbial Sensitivity Tests; D012703:Serotyping; D013290:Streptococcal Infections / Q000382:microbiology*; D013292:Streptococcus agalactiae / Q000145:classification* / Q000187:drug effects*; D014774:Virulence